StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

Core structure exploration tiers

Rule-based Catalog Exploration Score from SMILES similarity, approved/clinical tags, family network size, and SAR metadata. It does not predict efficacy, safety, or development success.

StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

Core 후보 44파생 후보 15439 패밀리

HighHigh exploration priority6

Highest Exploration Score percentile in this pool (X-S bin)

High exploration priority2DStructureClassExploration ScoreFactors
High
DM1
DM1 / maytansinoid payload family · Payload
Maytansinoid68패밀리 core · Payload core · SMILES 확보
High
MMAE
MMAE (auristatin) payload family · Payload
ADC payload66패밀리 core · Payload core · SMILES 확보
High
SG3199
PBD dimer ADC payload family · Payload
ADC payload65패밀리 core · Payload core · SMILES 확보
High
Duocarmycin SA
Duocarmycin CPI ADC payload series · Payload
ADC payload63패밀리 core · Payload core · SMILES 확보
High
Exenatide
GLP-1 / incretin agonist series · Drug
GLP-1 / incretin59패밀리 core · SMILES 확보
High
Gefitinib
EGFR tyrosine kinase inhibitor series · Drug
EGFR TKI59패밀리 core · SMILES 확보
HighDM1

DM1 / maytansinoid payload family · Payload · Maytansinoid

패밀리 core · Payload core · SMILES 확보

HighMMAE

MMAE (auristatin) payload family · Payload · ADC payload

패밀리 core · Payload core · SMILES 확보

HighSG3199

PBD dimer ADC payload family · Payload · ADC payload

패밀리 core · Payload core · SMILES 확보

Duocarmycin CPI ADC payload series · Payload · ADC payload

패밀리 core · Payload core · SMILES 확보

GLP-1 / incretin agonist series · Drug · GLP-1 / incretin

패밀리 core · SMILES 확보

EGFR tyrosine kinase inhibitor series · Drug · EGFR TKI

패밀리 core · SMILES 확보

MedMedium exploration priority10

Upper-mid Exploration Score percentile (X-A bin)

High exploration priority2DStructureClassExploration ScoreFactors
Med
Diazepam
Benzodiazepine GABA-A modulators · Drug
Anxiolytic · GABA58패밀리 core · SMILES 확보
Med
Imatinib
BCR-ABL TKI chemical series · Drug
BCR-ABL TKI58패밀리 core · SMILES 확보
Med
Sumatriptan
Migraine triptan series · Drug
Migraine · triptan58패밀리 core · SMILES 확보
Med
Levodopa
Parkinson dopaminergic / MAO-B series · Drug
Parkinson57패밀리 core · SMILES 확보 · 패밀리 9종
Med
Sotorasib
KRAS G12C inhibitor chemical landscape · Drug
KRAS inhibitor56패밀리 core · SMILES 확보
Med
Empagliflozin
SGLT2 inhibitor series · Drug
SGLT2 inhibitor55패밀리 core · SMILES 확보
Med
Irinotecan
SN-38 / irinotecan (TOP1) small-molecule series · Drug
TOP1 inhibitor55패밀리 core · SMILES 확보
Med
Methylphenidate
ADHD stimulant / non-stimulant series · Drug
ADHD55패밀리 core · SMILES 확보
Med
Venetoclax
BCL-2 BH3-mimetic inhibitor series · Drug
BCL-2 inhibitor55패밀리 core · SMILES 확보
Med
Exatecan
Exatecan / DXd (TOP1 inhibitor) payload family · Drug
TOP1 inhibitor54패밀리 core · SMILES 확보

Benzodiazepine GABA-A modulators · Drug · Anxiolytic · GABA

패밀리 core · SMILES 확보

BCR-ABL TKI chemical series · Drug · BCR-ABL TKI

패밀리 core · SMILES 확보

Migraine triptan series · Drug · Migraine · triptan

패밀리 core · SMILES 확보

Parkinson dopaminergic / MAO-B series · Drug · Parkinson

패밀리 core · SMILES 확보 · 패밀리 9종

KRAS G12C inhibitor chemical landscape · Drug · KRAS inhibitor

패밀리 core · SMILES 확보

SGLT2 inhibitor series · Drug · SGLT2 inhibitor

패밀리 core · SMILES 확보

SN-38 / irinotecan (TOP1) small-molecule series · Drug · TOP1 inhibitor

패밀리 core · SMILES 확보

ADHD stimulant / non-stimulant series · Drug · ADHD

패밀리 core · SMILES 확보

BCL-2 BH3-mimetic inhibitor series · Drug · BCL-2 inhibitor

패밀리 core · SMILES 확보

Exatecan / DXd (TOP1 inhibitor) payload family · Drug · TOP1 inhibitor

패밀리 core · SMILES 확보

MedMedium exploration priority15

Mid-pool Exploration Score (X-B bin)

High exploration priority2DStructureClassExploration ScoreFactors
Med
Ruxolitinib
JAK inhibitor chemical series · Drug
JAK inhibitor54패밀리 core · SMILES 확보
Med
Atorvastatin
Statin HMG-CoA reductase inhibitor series · Drug
Statin / HMG-CoA53패밀리 core · SMILES 확보
Med
Fluoxetine
SSRI / SNRI antidepressant series · Drug
Antidepressant · SSRI/SNRI53패밀리 core · SMILES 확보
Med
Ibrutinib
BTK inhibitor chemical series · Drug
BTK inhibitor53패밀리 core · SMILES 확보
Med
Gabapentin
Neuropathic gabapentinoid / SNRI series · Drug
Neuropathic · gabapentinoid52패밀리 core · SMILES 확보
Med
Paclitaxel
Taxane diterpenoid series · Drug
Taxane / microtubule52패밀리 core · SMILES 확보
Med
Palbociclib
CDK4/6 inhibitor chemical series · Drug
CDK4/6 inhibitor52패밀리 core · SMILES 확보
Med
Selpercatinib
RET / MET / NTRK oncogene TKI series · Drug
RET / MET / NTRK TKI52패밀리 core · SMILES 확보
Med
Vemurafenib
BRAF / MEK inhibitor chemical series · Drug
BRAF / MEK52패밀리 core · SMILES 확보
Med
Aripiprazole
Atypical antipsychotic series · Drug
Antipsychotic51패밀리 core · SMILES 확보
Med
Olaparib
PARP inhibitor chemical series · Drug
PARP inhibitor51패밀리 core · SMILES 확보
Med
Zolpidem
Sleep / hypnotic series · Drug
Sleep · hypnotic51패밀리 core · SMILES 확보
Med
Alpelisib
PI3K / AKT / mTOR inhibitor series · Drug
PI3K / AKT / mTOR50패밀리 core · SMILES 확보
Med
Levetiracetam
Antiepileptic drug chemical series · Drug
Antiepileptic · AED50패밀리 core · SMILES 확보
Med
Ubrogepant
CGRP gepant migraine series · Drug
Migraine · CGRP gepant50패밀리 core · SMILES 확보

JAK inhibitor chemical series · Drug · JAK inhibitor

패밀리 core · SMILES 확보

Statin HMG-CoA reductase inhibitor series · Drug · Statin / HMG-CoA

패밀리 core · SMILES 확보

SSRI / SNRI antidepressant series · Drug · Antidepressant · SSRI/SNRI

패밀리 core · SMILES 확보

BTK inhibitor chemical series · Drug · BTK inhibitor

패밀리 core · SMILES 확보

Neuropathic gabapentinoid / SNRI series · Drug · Neuropathic · gabapentinoid

패밀리 core · SMILES 확보

Taxane diterpenoid series · Drug · Taxane / microtubule

패밀리 core · SMILES 확보

CDK4/6 inhibitor chemical series · Drug · CDK4/6 inhibitor

패밀리 core · SMILES 확보

RET / MET / NTRK oncogene TKI series · Drug · RET / MET / NTRK TKI

패밀리 core · SMILES 확보

BRAF / MEK inhibitor chemical series · Drug · BRAF / MEK

패밀리 core · SMILES 확보

Atypical antipsychotic series · Drug · Antipsychotic

패밀리 core · SMILES 확보

PARP inhibitor chemical series · Drug · PARP inhibitor

패밀리 core · SMILES 확보

Sleep / hypnotic series · Drug · Sleep · hypnotic

패밀리 core · SMILES 확보

PI3K / AKT / mTOR inhibitor series · Drug · PI3K / AKT / mTOR

패밀리 core · SMILES 확보

Antiepileptic drug chemical series · Drug · Antiepileptic · AED

패밀리 core · SMILES 확보

CGRP gepant migraine series · Drug · Migraine · CGRP gepant

패밀리 core · SMILES 확보

LowLow exploration priority19

Lower Exploration Score — still listed for inspection (X-C bin)

High exploration priority2DStructureClassExploration ScoreFactors
Low
ARV-110
PROTAC / bifunctional degrader series · Drug
PROTAC / degrader49패밀리 core · SMILES 확보
Low
Crizotinib
ALK / ROS1 TKI chemical series · Drug
ALK / ROS1 TKI49패밀리 core · SMILES 확보
Low
Donepezil
Cognitive modulator series · Drug
Cognition · dementia49패밀리 core · SMILES 확보
Low
Enlicitide
PCSK9 inhibitor chemical & modality series · Drug
PCSK9 / LDL-C49패밀리 core · SMILES 확보
Low
Fingolimod
MS S1P modulator series · Drug
MS · S1P49패밀리 core · SMILES 확보
Low
Riluzole
ALS neuroprotectant series · Drug
ALS49패밀리 core · SMILES 확보
Low
Daraxonrasib
Daraxonrasib · RAS(ON) · Drug
KRAS inhibitor48패밀리 core · SMILES 확보
Low
DXd
Exatecan / DXd (TOP1 inhibitor) payload family · Payload
TOP1 inhibitor48Payload core · SMILES 확보
Low
MRTX1133
KRAS G12D / RAS(ON) inhibitor series · Drug
KRAS inhibitor48패밀리 core · SMILES 확보
Low
DM4
DM1 / maytansinoid payload family · Payload
Maytansinoid46Payload core · SMILES 확보
Low
MMAF
MMAE (auristatin) payload family · Payload
ADC payload44Payload core · SMILES 확보
Low
Tesirine
PBD dimer ADC payload family · Payload
ADC payload43Payload core · SMILES 확보
Low
Seco-duocarmycin
Duocarmycin CPI ADC payload series · Payload
ADC payload41Payload core · SMILES 확보
Low
SMCC-DM1
DM1 / maytansinoid payload family · Linker
Maytansinoid40Linker hub · SMILES 확보
Low
CL2A
Exatecan / DXd (TOP1 inhibitor) payload family · Linker
TOP1 inhibitor38Linker hub · SMILES 확보
Low
GGFG
Exatecan / DXd (TOP1 inhibitor) payload family · Linker
TOP1 inhibitor38Linker hub · SMILES 확보
Low
SMCC
Daraxonrasib · RAS(ON) · Linker
KRAS inhibitor38Linker hub · SMILES 확보
Low
Sulfo-SPDB
Daraxonrasib · RAS(ON) · Linker
KRAS inhibitor38Linker hub · SMILES 확보
Low
Val-Cit
MMAE (auristatin) payload family · Linker
ADC payload36Linker hub · SMILES 확보

PROTAC / bifunctional degrader series · Drug · PROTAC / degrader

패밀리 core · SMILES 확보

ALK / ROS1 TKI chemical series · Drug · ALK / ROS1 TKI

패밀리 core · SMILES 확보

Cognitive modulator series · Drug · Cognition · dementia

패밀리 core · SMILES 확보

PCSK9 inhibitor chemical & modality series · Drug · PCSK9 / LDL-C

패밀리 core · SMILES 확보

MS S1P modulator series · Drug · MS · S1P

패밀리 core · SMILES 확보

ALS neuroprotectant series · Drug · ALS

패밀리 core · SMILES 확보

Daraxonrasib · RAS(ON) · Drug · KRAS inhibitor

패밀리 core · SMILES 확보

LowDXd

Exatecan / DXd (TOP1 inhibitor) payload family · Payload · TOP1 inhibitor

Payload core · SMILES 확보

KRAS G12D / RAS(ON) inhibitor series · Drug · KRAS inhibitor

패밀리 core · SMILES 확보

LowDM4

DM1 / maytansinoid payload family · Payload · Maytansinoid

Payload core · SMILES 확보

LowMMAF

MMAE (auristatin) payload family · Payload · ADC payload

Payload core · SMILES 확보

PBD dimer ADC payload family · Payload · ADC payload

Payload core · SMILES 확보

Duocarmycin CPI ADC payload series · Payload · ADC payload

Payload core · SMILES 확보

DM1 / maytansinoid payload family · Linker · Maytansinoid

Linker hub · SMILES 확보

LowCL2A

Exatecan / DXd (TOP1 inhibitor) payload family · Linker · TOP1 inhibitor

Linker hub · SMILES 확보

LowGGFG

Exatecan / DXd (TOP1 inhibitor) payload family · Linker · TOP1 inhibitor

Linker hub · SMILES 확보

LowSMCC

Daraxonrasib · RAS(ON) · Linker · KRAS inhibitor

Linker hub · SMILES 확보

Daraxonrasib · RAS(ON) · Linker · KRAS inhibitor

Linker hub · SMILES 확보

MMAE (auristatin) payload family · Linker · ADC payload

Linker hub · SMILES 확보

Actual weights, formula and input limits

Exploration score method

StructureMoa ranks are a rule-based Exploration Score. An LLM does not predict activity or efficacy. Role, SMILES, and relation signals inside each family are summed and cut into High / Medium / Low exploration priority.

Core tab

  • scaffold / payload / linker role weights
  • family center-compound bonus
  • SMILES source (db · known · pubchem · inherited)
  • relation-edge count and derived-child count

Derivative tab

  • drug / derivative / adc candidates
  • similarity to family center via Morgan fingerprint, radius 2, 2048 bits, Tanimoto
  • Approval, clinical and lead tag bonuses have been removed.

Explore tab

  • sparse SAR, cross-scaffold pairs, expansion leaves
  • weakly linked nodes and catalog-coverage gaps
  • relation graph + stored Morgan fingerprints
  • category filters

Exploration-priority bins

  • High (X-S): top ~12%
  • Medium (X-A/X-B): ~12–62%
  • Low (X-C): remainder (pools under 5 compounds stay Medium)

Internal exploration metric based on catalog and structural signals. Not a prediction of efficacy, safety, potency, or development success.

Full methodology

평가 시각: 2026. 10. 28. 오후 6:32:15 · 캐시 5분 · 전체 패밀리